Search research articles
Contact Us
Filters
Showing results (61-70 of 144) with videos related to
Page
of 15
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2017
What treatment in 2017 for inoperable pancreatic cancers?
J Taieb, A-L Pointet, J L Van Laethem, et al.
Journal of Surgical Oncology
|
December 19, 2007
Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival
R Rosenberg, H Nekarda, F Zimmermann, et al.
British Journal of Cancer
|
November 23, 2013
Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance
M M Gerlach, F Merz, G Wichmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 31, 2007
Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial
S Lorenzen, M Hentrich, C Haberl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 10, 2012
Her2/neu testing in gastric cancer: evaluating the risk of sampling errors
V S Warneke, H-M Behrens, C Böger, et al.
Critical Reviews in Oncology/Hematology
|
February 5, 2008
Weekly docetaxel monotherapy for advanced gastric or esophagogastric junction cancer. Results of a phase II study in elderly patients or patients with impaired performance status
K Abbrederis, S Lorenzen, L Fischer von Weikersthal, et al.
Endoscopy
|
November 18, 2006
Delays in diagnosis and therapy of gastric cancer and esophageal adenocarcinoma
R Witzig, B Schönberger, U Fink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 8, 2022
Modified Glasgow prognostic score (mGPS) is correlated with sarcopenia and dominates the prognostic role of baseline body composition parameters in advanced gastric and esophagogastric junction cancer patients undergoing first-line treatment from the phase III EXPAND trial
U T Hacker, D Hasenclever, R Baber, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|
December 1, 2011
[Current S3 guidelines on surgical treatment of gastric carcinoma]
H-J Meyer, A H Hölscher, F Lordick, et al.
The British Journal of Surgery
|
April 24, 2014
Discrepancies between medical oncologists and surgeons in assessment of resectability and indication for chemotherapy in patients with colorectal liver metastases
K Homayounfar, A Bleckmann, H-J Helms, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 144) with videos related to
Sort By:
Page
of 15
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2017
What treatment in 2017 for inoperable pancreatic cancers?
J Taieb, A-L Pointet, J L Van Laethem, et al.
Journal of Surgical Oncology
|
December 19, 2007
Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival
R Rosenberg, H Nekarda, F Zimmermann, et al.
British Journal of Cancer
|
November 23, 2013
Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance
M M Gerlach, F Merz, G Wichmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 31, 2007
Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial
S Lorenzen, M Hentrich, C Haberl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 10, 2012
Her2/neu testing in gastric cancer: evaluating the risk of sampling errors
V S Warneke, H-M Behrens, C Böger, et al.
Critical Reviews in Oncology/Hematology
|
February 5, 2008
Weekly docetaxel monotherapy for advanced gastric or esophagogastric junction cancer. Results of a phase II study in elderly patients or patients with impaired performance status
K Abbrederis, S Lorenzen, L Fischer von Weikersthal, et al.
Endoscopy
|
November 18, 2006
Delays in diagnosis and therapy of gastric cancer and esophageal adenocarcinoma
R Witzig, B Schönberger, U Fink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 8, 2022
Modified Glasgow prognostic score (mGPS) is correlated with sarcopenia and dominates the prognostic role of baseline body composition parameters in advanced gastric and esophagogastric junction cancer patients undergoing first-line treatment from the phase III EXPAND trial
U T Hacker, D Hasenclever, R Baber, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|
December 1, 2011
[Current S3 guidelines on surgical treatment of gastric carcinoma]
H-J Meyer, A H Hölscher, F Lordick, et al.
The British Journal of Surgery
|
April 24, 2014
Discrepancies between medical oncologists and surgeons in assessment of resectability and indication for chemotherapy in patients with colorectal liver metastases
K Homayounfar, A Bleckmann, H-J Helms, et al.
Page
of 15